LUNGevity Foundation shared a post on LinkedIn:
“”If we can optimize conditions around the tumor so the immune system effectively fights the cancer, it can be like a personal army—ready to stop any lingering cancer cells before they can do harm,” Erin Schenk, MD, PhD (University of Colorado).
Read our latest blog with Dr. Schenk, LUNGevity’s 2021 Career Development Awardee, to learn how her research is getting attention and what it could mean for the lung cancer community.”
More posts featuring LUNGevity Foundation on OncoDaily.